Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroleptanalgesia for Postoperative Delirium Prevention
NCT05068180Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Oct 2021
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of droperidol and fentanyl in postoperative delirium (POD) (2 arms), sponsored by Renji Hospital. Primary endpoint: Incidence of postoperative delirium at 7 days. Status: unknown.
02
Drugs
droperidolfentanyl
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05068180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05068180.